Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events

Abstract

Concentrations of HDL-C achieved with gemfibrozil treatment predicted a significant reduction in CHD events in patients with low HDL-C levels. However, the change in HDL-C levels only partially explained the beneficial effect of gemfibrozil.